UFPT is the ticker symbol for UFP TECHNOLOGIES INC, a publicly traded Healthcare sector company listed on Nasdaq. 13F Pro tracks UFPT with AI-powered analysis, a 32-signal quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is UFPT a good stock to buy?

13F Pro's AI ranking engine scores UFPT at 63.1/100, ranked #661 of 2,961 stocks based on 32 fundamental signals including profitability, growth, balance sheet strength, and free cash flow. The full AI verdict and bull/bear case for UFPT is available at https://13fpro.ai/company/UFPT. Not investment advice — review the underlying SEC filings before making any trade.

Where does 13F Pro source UFPT data?

All UFP TECHNOLOGIES INC fundamentals and ownership data come directly from SEC EDGAR. UFP TECHNOLOGIES INC files with the SEC under CIK 914156. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

UFP TECHNOLOGIES INC(UFPT)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

UFP TECHNOLOGIES INC (UFPT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores UFPT at 63.1/100 on a 32-signal composite quality model, placing it at rank #661 of 2,961 stocks — the top 25% of the AI-ranked universe. UFPT scores in the top quartile across balance sheet strength (87.3), revenue growth (82.9). Areas of concern include institutional flow (25.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 46.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), UFP TECHNOLOGIES INC reports quarterly revenue of $174.0M, net income of $20.9M, an operating margin of 16.2%. Top institutional holders of UFPT by reported 13-F value include BlackRock, CONGRESS ASSET MANAGEMENT, WASATCH ADVISORS, based on the most recent SEC filings. UFPT trades on the Nasdaq exchange and files with the SEC under CIK 914156. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate UFPT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for UFP TECHNOLOGIES INC directly from SEC EDGAR.

AI Quality Score

63.1/100

AI Rank

#661

Revenue

$174.0M

Net Income

$20.9M

Operating Margin

16.2%

UFPT key financials by period

UFP TECHNOLOGIES INC reported revenue, net income and margins by fiscal period, from SEC filings.
Period	Form	Revenue	Net income	Operating margin
FY 2025	10-K	$602.8M	$68.3M	15.3%
FY 2024	10-K	$504.4M	$59.0M	16.0%
FY 2023	10-K	$400.1M	$44.9M	14.4%
FY 2022	10-K	$353.8M	$41.8M	15.7%
FY 2021	10-K	$206.3M	$15.9M	10.3%
FY 2020	10-K	$179.4M	$13.4M	9.3%

Institutions holding UFPT

Institutional investors reporting a position in UFP TECHNOLOGIES INC on SEC Form 13F.
Institution	Shares	Value	Reported
BlackRock	1,141,410	$302.6M	2026-06-30
CONGRESS ASSET MANAGEMENT	687,439	$182.3M	2026-06-30
WASATCH ADVISORS	683,262	$181.2M	2026-06-30
Neuberger Berman Group	537,038	$142.4M	2026-06-30
PRICE T ROWE ASSOCIATES	357,331	$94.7M	2026-06-30
Boston Walden	336,278	$89.2M	2026-06-30
VANGUARD CAPITAL MANAGEMENT	329,623	$87.4M	2026-06-30
STATE STREET	312,811	$82.9M	2026-06-30
AMERICAN CENTURY COMPANIES	279,976	$74.2M	2026-06-30
UBS Group AG	254,740	$67.5M	2026-06-30

SEC EDGAR: CIK 914156 →

UFP TECHNOLOGIES INC

UFPT

NasdaqMid CapHealthcare

13F Pro Quality Score

63.1/100

Rank #661 of 2,961 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

82.9/100

Profitability

66.9/100

Balance Sheet

87.3/100

Earnings Quality

61.5/100

Free Cash Flow

54.8/100

Institutional Flow

25.6/100

Revenue Scale

41.0/100

Dilution Risk

46.9/100

Price Chart

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

What's Driving UFPT's Business? Latest 10-Q Breakdown

AI-extracted from the 10-Q filed 2026-08-06 — Q2 FY2026 (six months ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

UFP Technologies grew six-month revenue 9.6% to $328.2M with organic growth of 6.8%, driven by Medical market strength, while gross margin improved to 29.0% despite SG&A cost inflation.

Biggest Revenue Drivers

Products$324.3M+10.1% YoY

Biggest Revenue Drivers

Total revenue: $328.2M+9.6% YoY

Products$324.3M+10.1% YoY

Largest Expense Items

Cost of sales$232.9M+9.0% YoY

Gross margin improved to 29.0% from 28.6%, driven by increased operating efficiencies.

Selling, general & administrative expenses$43.8M+17.0% YoY

Increased headcount and back-office resources ($2.6M), plus share-based compensation ($1.6M), partially due to CEO transition costs.

Margins: Gross margin expanded to 29.0% for H1 2026 from 28.6% in H1 2025, driven by increased operating efficiencies and leverage on organic sales growth. However, SG&A as a percentage of sales increased to 13.3% from 12.5%, reflecting CEO transition costs and higher headcount.

Watch Items from the Filing

Two customers represent 25.5% and 21.5% of H1 2026 revenue; customer concentration risk remains material with potential for reduced orders.
AJR Labor Issue caused significant workforce turnover in 2025, creating operational inefficiencies and training burdens; productivity impact ongoing through H1 2026.
Cyber Incident detected February 14, 2026; stated as immaterial to date but investigation ongoing and could have future material impact.
Tariff refund process launched April 2026; tariff landscape remains dynamic under current administration, creating ongoing uncertainty and potential cost volatility.
Outstanding debt of $117.3M against $150M revolving facility; company in compliance with all covenants and weighted average interest rate at 5.0%.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →